Abilify and Cobamamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Cobamamide (dibencozide). Common drug interactions include ankle fracture among females and loss of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Cobamamide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Cobamamide?

Cobamamide has active ingredients of dibencozide. eHealthMe is studying from 1,046 Cobamamide users. Check the latest studies of Cobamamide.



On Jul, 09, 2026

13 people who take Abilify and Cobamamide together, and have interactions are studied.

Abilify and Cobamamide drug interactions.

What are the common drug interactions of Abilify and Cobamamide, by gender? *:

female:

  1. Ankle fracture
  2. Brain injury
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Fall
  5. Intervertebral disc protrusion (spinal disc protrusion)
  6. Nerve injury
  7. Pneumonia
  8. Psychotic disorder
  9. Pyrexia (fever)
  10. Rash

male:

  1. Loss of consciousness
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Food craving
  4. Hunger
  5. Nausea (feeling of having an urge to vomit)
  6. Polydipsia (excessive thirst)
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Upper respiratory tract infection
  10. Asthma

What are the common drug interactions of Abilify and Cobamamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Asthma
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Pain
  5. Pain in extremity
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Sinusitis (inflammation of sinus)
  8. Tooth abscess (pus formation in tooth)
  9. Tooth infection
  10. Upper respiratory tract infection

60+:

n/a

What are the existing conditions these people have? *

  1. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 6 people, 46.15%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 30.77%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 15.38%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
  5. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 1 person, 7.69%
  6. Cystic Fibrosis (disease of the secretary glands): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Cobamamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Cobamamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cobamamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cobamamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and dibencozide (the active ingredients of Abilify and Cobamamide, respectively), and Abilify and Cobamamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: